OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2025
(5)
2023
(3)
2022
(1)
2021
(1)
2020
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
SYNPO2 upregulation is an unfavorable prognostic factor for nasopharyngeal carcinoma patients.
Not available
S-EPMC10378812
|
biostudies-literature
Cite
Predicting Clinically Significant Prostate Cancer Using Urine Metabolomics via Liquid Chromatography Mass Spectrometry.
Not available
S-EPMC11937347
|
biostudies-literature
Cite
Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease.
Not available
S-EPMC10590775
|
biostudies-literature
Cite
Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.
Not available
S-EPMC7350738
|
biostudies-literature
Cite
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
Not available
S-EPMC10566053
|
biostudies-literature
Cite
Clinical impact of pharmacogenetic risk variants in a large chinese cohort.
Not available
S-EPMC12241563
|
biostudies-literature
Cite
Population-specific polygenic risk scores for people of Han Chinese ancestry.
Not available
S-EPMC12675292
|
biostudies-literature
Cite
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Not available
S-EPMC12675286
|
biostudies-literature
Cite
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants.
Not available
S-EPMC8967717
|
biostudies-literature
Cite
Low-Density Lipoprotein Cholesterol and Mortality in Patients With Intracerebral Hemorrhage in Taiwan.
Not available
S-EPMC8802633
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets